Free Trial

UnitedHealth Group (NYSE:UNH) Shares Down 0.9%

→ Warren Buffett's "mystery stock" (From Stansberry Research) (Ad)

UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report) shares fell 0.9% on Tuesday . The stock traded as low as $483.38 and last traded at $484.78. 609,725 shares traded hands during mid-day trading, a decline of 86% from the average session volume of 4,432,396 shares. The stock had previously closed at $489.03.

Analyst Ratings Changes

UNH has been the subject of several research reports. Royal Bank of Canada lowered their price objective on shares of UnitedHealth Group from $596.00 to $555.00 and set an "outperform" rating for the company in a research report on Wednesday, April 17th. TD Cowen decreased their price objective on UnitedHealth Group from $607.00 to $546.00 and set a "buy" rating on the stock in a research report on Wednesday, April 10th. StockNews.com downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Thursday, April 18th. Oppenheimer reiterated an "outperform" rating and set a $610.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Finally, Truist Financial reaffirmed a "buy" rating and set a $600.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Four investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $570.05.


Check Out Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Trading Down 1.1 %

The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The company has a market capitalization of $445.04 billion, a PE ratio of 29.57, a price-to-earnings-growth ratio of 1.43 and a beta of 0.54. The company's fifty day moving average is $484.44 and its 200-day moving average is $513.42.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts' consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm's revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter last year, the company earned $6.26 earnings per share. On average, analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.55%. UnitedHealth Group's dividend payout ratio is presently 45.97%.

Insider Activity at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the company's stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,236 shares of the company's stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company's stock, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the business's stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Norges Bank acquired a new position in shares of UnitedHealth Group in the fourth quarter worth about $5,802,231,000. International Assets Investment Management LLC grew its holdings in UnitedHealth Group by 53,573.1% in the fourth quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate's stock valued at $1,238,515,000 after purchasing an additional 2,348,107 shares during the period. Jennison Associates LLC raised its stake in shares of UnitedHealth Group by 49.3% during the 4th quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate's stock worth $1,904,670,000 after buying an additional 1,195,352 shares during the period. Mawer Investment Management Ltd. grew its stake in UnitedHealth Group by 75.0% in the 3rd quarter. Mawer Investment Management Ltd. now owns 2,011,150 shares of the healthcare conglomerate's stock valued at $1,014,002,000 after acquiring an additional 862,024 shares during the period. Finally, California Public Employees Retirement System raised its position in UnitedHealth Group by 35.9% during the fourth quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate's stock worth $1,627,311,000 after acquiring an additional 815,822 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Should you invest $1,000 in UnitedHealth Group right now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Featured Articles and Offers

Meteoric Rise of Chipotle Mexican Grill Stock is Not Over

Meteoric Rise of Chipotle Mexican Grill Stock is Not Over

The price action in Chipotle Mexican Grill NYSE: CMG has been smoking hot, and it is not over yet. The 1100% gain posted since 2017 is the tip of the iceberg for this fast-growing, fast-casual restaur

Search Headlines: